J. S. Yadav et al. / Tetrahedron Letters 45 (2004) 7577–7579
7579
4. (a) Reddy, A. V.; Ravinder, K.; Reddy, V. L. N.; Goud, T.
V.; Ravikanth, V.; Venkateswarlu, Y. Synth. Commun.
2003, 33, 3687–3694; (b) Mahadevan, A.; Sard, H.; Gonz-
alez, M.; McKew, J. C. Tetrahedron Lett. 2003, 44, 4589–
4591; (c) Chakrabarty, M.; Ghosh, N.; Basak, R.; Hari-
gaya, Y. Tetrahedron Lett. 2002, 43, 4075–4078; (d) Roomi,
M.; MacDonald, S. Can. J. Chem. 1970, 48, 139–142.
5. (a) Mi, X.; Luo, S.; He, J.; Cheng, J.-P. Tetrahedron Lett.
2004, 45, 4567–4570, and references cited therein; (b)
Bandgar, B. P.; Shaikh, K. A. Tetrahedron Lett. 2003, 44,
1959–1962.
phenyl acetylene. In the absence of catalyst, no reaction
was observed. As solvent, toluene appeared to give the
best results. Among the various Lewis acids such as
InCl3, InBr3, InI3, YCl3 and BiCl3 tested, gallium triha-
lides were found to be the most effective for this conver-
sion. In(OTf)3 (20mol%) was also worked well to afford
the corresponding bis(indolyl)phenylethane in 12h
under reflux. The scope and generality of this process
is illustrated with respect to various indoles and the
results are presented in Table 1.
6. Matsuo, J.-I.; Kobayashi, S. CHEMTRACTS 2000, 13,
431–434.
In summary we have described a simple, convenient and
efficient protocol for the synthesis of bis(indolyl)phenyl-
ethanes from indoles and phenylacetylene using
10mol% of GaX3 as catalyst. GaCl3 and GaBr3 are
solid and stable to air or moisture and are easy to handle
even on multi-gram scales and are found to activate
alkynes very effectively under mild conditions. This
process offers several advantages such as high conver-
sions, high selectivity, experimental simplicity and high
catalytic activity, which makes it a useful and attractive
strategy for the preparation of bis(indolyl)phenylethanes
in a single step operation.
7. (a) Chatani, N.; Inoue, H.; Kotsuma, T.; Murai, S. J. Am.
Chem. Soc. 2002, 124, 10294–10295; (b) Inoue, H.; Chatani,
N.; Murai, S. J. Org. Chem. 2002, 67, 1414–1417; (c)
Yamaguchi, M.; Tsukagoshi, T.; Arisawa, M. J. Am. Chem.
Soc. 1999, 121, 4074–4075; (d) Asao, N.; Asano, T.; Ohishi,
T.; Yamamoto, Y. J. Am. Chem. Soc. 2000, 122, 4817–4818.
8. (a) Kobayashi, K.; Arisawa, M.; Yamaguchi, M. J. Am.
Chem. Soc. 2002, 124, 8528–8529; (b) Viswanathan, G. S.;
Wang, M.; Li, C.-J. Angew. Chem., Int. Ed. 2002, 41, 2138–
2141; (c) Viswanathan, G. S.; Li, C.-J. Synlett 2002, 1553–
1555; (d) Viswanathan, G. S.; Li, C.-J. Tetrahedron Lett.
2002, 43, 1613–1615.
9. A mixture of phenylacetylene (1.2mmol), indole (2mmol),
gallium trihalide (0.10mmol) in toluene (10mL) was stirred
at room temperature for the appropriate time (see Table 1).
After completion of the reaction as indicated by TLC, the
reaction mixture was diluted with water and extracted with
ethyl acetate (2 · 10mL). The combined organic layers were
dried over anhydrous Na2SO4, concentrated in vacuo and
purified by column chromatography on silica gel (Merck,
100–200 mesh, ethyl acetate–hexane, 1.5:8.5) to afford the
pure bis(indolyl)phenylethane. Spectroscopic data for
selected products: 3e: 4-Nitro-3-[1-{4-nitro-1H-3-indolyl}-
1-phenylethyl]-1H-indole: yellow solid, mp = 283–286ꢁC.
IR (KBr): mmax: 3436, 2983, 1740, 1532, 1468, 1376, 1331,
1242, 1046, 786cmÀ1. 1H NMR (400MHz, CDCl3): d 11.32
(br s, 2H, NH), 7.98 (s, 2H), 7.90 (d, J = 9.2Hz, 2H), 7.44
(d, J = 9.2Hz, 2H), 7.35–7.22 (m, 5H), 6.96 (s, 2H), 2.36 (s,
3H). FAB Mass: m/z (%): 427 (M+1, 35), 411 (55), 349 (12),
313 (5), 289 (5), 265 (40), 219 (8), 191 (5), 154 (18),123 (10),
109 (8), 95 (35), 81 (40), 69 (65), 57 (100). HRMS calcd for
C24H19N4O4: 427.1406. Found: 427.1413 (M+1). 3f: 4 -
Bromo-3-[1-4-bromo-1H-3-indolyl-1-phenylethyl]-1H-
Acknowledgements
M.K.G. thanks the Council of Scientific and Industrial
Research New Delhi for the award of a fellowship.
References and notes
1. Kam, T. S. In Alkaloids, Chemical and Biological Perspec-
tives; Pelletier, S. W., Ed.; Pergamon: Amsterdam, 1999;
Vol. 4, 429 pp.
2. (a) Irie, T.; Kubushirs, K.; Suzuki, K.; Tsukazaki, K.;
Umezawa, K.; Nozawa, S. Anticancer Res. 1999, 31, 3061–
3066; (b) Umezawa, K.; Tangiguchi, T.; Toi, M.; Ohse, T.;
Ishutsumi, T.; Yamamoto, T.; Koyano, T.; Ishizuka, M.
Drugs Exp. Clin. Res. 1996, 22, 35–40; (c) Amino, N.; Ohse,
T.; Koyano, T.; Umezawa, K. Anticancer Res. 1996, 16, 55–
59; (d) Bifulco, G.; Bruno, I.; Riccio, R.; Lavayre, J.;
Bourdy, G. J. Nat. Prod. 1995, 58, 1254–1260; (e)
Umezawa, K.; Ohse, T.; Koyano, T.; Takahashi, Y.
Anticancer Res. 1994, 14, 2413–2417; (f) Morris, S. A.;
Anderson, R. A. Tetrahedron 1990, 46, 715–720.
indole: brown solid, mp = 216–220ꢁC. IR (KBr): mmax
3432, 2982, 1723, 1562, 1456, 1410, 1374, 1330, 1217, 1102,
1050, 881, 767, 702, 666, 584cmÀ1 1H NMR (200MHz,
:
.
3. (a) Ji, S.-J.; Zhou, M.-F.; Gu, D.-G.; Jiang, Z.-Q.;
Loh, T.-P. Eur. J. Org. Chem. 2004, 1584–1587, and
references cited therein; (b) Bartoli, G.; Bosco, M.; Foglia,
G.; Giuliani, A.; Marcantoni, E.; Sambri, L. Synthesis
2004, 895–900, and references cited therein; (c) Ji, S.-J.;
Zhon, M.-F.; Gu, D.-G.; Wang, S. Y.; Loh, T.-P. Synlett
2003, 2077–2079; (d) Ramesh, C.; Ravindranath, N.; Das,
B. J. Chem. Res. (S). 2003, 72–74; (e) Nagarajan, R.;
Perumal, P. T. Tetrahedron 2002, 58, 1229–1232; (f) Yadav,
J. S.; Subba Reddy, B. V.; Murthy, Ch. V. S. R.; Madan,
Ch. Synthesis 2001, 783–787; (g) Babu, G.; Sridhar, N.;
Perumal, P. T. Synth. Commun. 2000, 30, 1609–1614; (h)
Chen, D.; Yu, L.; Wang, P. G. Tetrahedron Lett. 1996, 37,
4467–4470; (i) Earle, M. J.; Fairhurst, R. A.; Heaney, H.
Tetrahedron Lett. 1991, 32, 6171–6174.
CDCl3): d 7.90 (br s, 2H, NH), 7.38–7.20 (m, 11H), 6.60 (d,
J = 6.5Hz, 2H), 2.30 (s, 3H). FAB Mass: m/z (%): 494 (M+,
30), 479 (45), 399 (8), 391 (10), 298 (30), 279 (5), 219 (8), 204
(5), 191 (5), 167 (12), 154 (50), 136 (40), 115 (15), 95 (45), 81
(48), 69 (60), 57 (100). HRMS calcd for C24H19N2Br2:
492.9914. Found: 492.9923 (M+1). 3g: 3-[1-(5-cyano-1H-3-
indolyl)-1-phenylethyl]-1H-5-indolecarbonitrile: yellowish
solid, mp = 192–194ꢁC. IR (KBr): mmax: 3418, 2885, 2823,
2254, 2215, 2127, 1645, 1475, 1378, 1339, 1243, 1103, 1026,
1
1004, 824, 763, 623cmÀ1. H NMR (400MHz, CDCl3): d
11.22 (br s, 2H, NH), 7.48 (d, J = 8.4Hz, 2H), 7.39 (s, 2H),
7.30–7.22 (m, 7H), 6.82 (s, 2H), 2.30 (s, 3H). EIMS: m/z
(%): 386 (M+, 40), 372 (100), 309 (10), 229 (12), 185 (7), 140
(5). HRMS calcd for C26H18N4: 386.1531. Found:
386.1525.